HomeCompareATRI vs CHD

ATRI vs CHD: Dividend Comparison 2026

ATRI yields 1.91% · CHD yields 1.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ATRI wins by $718.4K in total portfolio value
10 years
ATRI
ATRI
● Live price
1.91%
Share price
$459.92
Annual div
$8.80
5Y div CAGR
70.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$744.8K
Annual income
$498,113.36
Full ATRI calculator →
CHD
CHD
● Live price
1.27%
Share price
$93.91
Annual div
$1.19
5Y div CAGR
23.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.4K
Annual income
$1,292.51
Full CHD calculator →

Portfolio growth — ATRI vs CHD

📍 ATRI pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodATRICHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ATRI + CHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ATRI pays
CHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATRI
Annual income on $10K today (after 15% tax)
$162.64/yr
After 10yr DRIP, annual income (after tax)
$423,396.36/yr
CHD
Annual income on $10K today (after 15% tax)
$107.94/yr
After 10yr DRIP, annual income (after tax)
$1,098.63/yr
At 15% tax rate, ATRI beats the other by $422,297.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATRI + CHD for your $10,000?

ATRI: 50%CHD: 50%
100% CHD50/50100% ATRI
Portfolio after 10yr
$385.6K
Annual income
$249,702.93/yr
Blended yield
64.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CHD right now

ATRI
Analyst Ratings
1
Sell
Consensus: Sell
Altman Z
26.0
Piotroski
6/9
CHD
Analyst Ratings
18
Buy
15
Hold
1
Sell
Consensus: Buy
Price Target
$98.40
+4.8% upside vs current
Range: $82.00 — $110.00
Altman Z
4.9
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATRI buys
0
CHD buys
0
No recent congressional trades found for ATRI or CHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricATRICHD
Forward yield1.91%1.27%
Annual dividend / share$8.80$1.19
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR70.5%23.1%
Portfolio after 10y$744.8K$26.4K
Annual income after 10y$498,113.36$1,292.51
Total dividends collected$700.3K$5.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusSellBuy

Year-by-year: ATRI vs CHD ($10,000, DRIP)

YearATRI PortfolioATRI Income/yrCHD PortfolioCHD Income/yrGap
1← crossover$11,026$326.23$10,856$156.32+$170.00ATRI
2$12,371$573.18$11,811$195.24+$560.00ATRI
3$14,262$1,024.75$12,883$244.38+$1.4KATRI
4$17,143$1,882.46$14,091$306.64+$3.1KATRI
5$21,948$3,605.53$15,463$385.88+$6.5KATRI
6$30,840$7,355.78$17,033$487.17+$13.8KATRI
7$49,469$16,469.85$18,843$617.36+$30.6KATRI
8$95,028$42,096.26$20,947$785.72+$74.1KATRI
9$230,536$128,855.34$23,419$1,004.91+$207.1KATRI
10$744,786$498,113.36$26,350$1,292.51+$718.4KATRI

ATRI vs CHD: Complete Analysis 2026

ATRIStock

Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery. Its ophthalmic products include specialized medical devices that disinfect contact lenses; and a line of balloon catheters, which are used for the treatment of nasolacrimal duct obstruction in children and adults. The company also manufactures instrumentation and associated disposables that measure the activated clotting time of blood; and products for safe needle and scalpel blade containment. In addition, it manufactures inflation systems and valves used in marine and aviation safety products; components used in inflatable survival products and structures; and one-way and two-way pressure relief valves that protect sensitive electronics and other products during transport in other medical and non-medical applications. The company sells its products to physicians, hospitals, clinics, and other treatment centers; and other equipment manufacturers through direct sales force, independent sales representatives, and distributors. Atrion Corporation was founded in 1944 and is headquartered in Allen, Texas.

Full ATRI Calculator →

CHDConsumer Staples

Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.

Full CHD Calculator →
📬

Get this ATRI vs CHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATRI vs SCHDATRI vs JEPIATRI vs OATRI vs KOATRI vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.